/Dexcom%20Inc%20logo%20on%20sign-by%20Michael%20Vi%20via%20Shutterstock.jpg)
Valued at a market cap of $27.4 billion, DexCom, Inc. (DXCM) operates in the medical devices sector. The California-based company specializes in continuous glucose monitoring systems that provide real-time blood glucose data to aid diabetes management.
Companies valued at $10 billion or more are generally considered “large-cap” stocks, and DexCom fits this criterion perfectly, exceeding the mark. DexCom is renowned for its advanced continuous glucose monitoring systems, including the Dexcom G6 and G7, which provide real-time glucose data and trend insights, transforming diabetes management with over 20,000 users in its Dexcom Warrior community.